BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8547667)

  • 1. Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.
    Deeg HJ; Socié G; Schoch G; Henry-Amar M; Witherspoon RP; Devergie A; Sullivan KM; Gluckman E; Storb R
    Blood; 1996 Jan; 87(1):386-92. PubMed ID: 8547667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia.
    Crawford SW; Longton G; Storb R
    Bone Marrow Transplant; 1993 Sep; 12(3):225-31. PubMed ID: 8241981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome.
    Guardiola P; Socié G; Li X; Ribaud P; Devergie A; Espérou H; Richard P; Traineau R; Janin A; Gluckman E
    Blood; 2004 Jan; 103(1):73-7. PubMed ID: 12946993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.
    Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E
    N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary malignancies after bone marrow transplantation in adults.
    Lowsky R; Lipton J; Fyles G; Minden M; Meharchand J; Tejpar I; Atkins H; Sutcliffe S; Messner H
    J Clin Oncol; 1994 Oct; 12(10):2187-92. PubMed ID: 7931488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
    Castro-Malaspina H; Childs B; Laver J; Shank B; Brochstein J; Gillio A; Flomenberg N; Young J; Boulad F; Black P
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):847-54. PubMed ID: 8040033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cape Town experience with haematopoietic stem cell transplantation: the paediatric programme.
    Roux P; Novitzky N
    S Afr Med J; 2000 Aug; 90(8):804-11. PubMed ID: 11022631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marrow transplant experience for children with severe aplastic anemia.
    Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
    Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation in patients with Fanconi anemia: experience with cyclophosphamide and total body irradiation conditioning regimen.
    Solh H; Rao K; Martins da Cunha AM; Padmos A; Sackey K; Ernst P; Spence D; Clink H
    Pediatr Hematol Oncol; 1997; 14(1):67-72. PubMed ID: 9021815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia.
    Bonfim C; Ribeiro L; Nichele S; Loth G; Bitencourt M; Koliski A; Kuwahara C; Fabro AL; Pereira NF; Pilonetto D; Thakar M; Kiem HP; Page K; Fuchs EJ; Eapen M; Pasquini R
    Biol Blood Marrow Transplant; 2017 Feb; 23(2):310-317. PubMed ID: 27832981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center.
    Gaziev D; Giardini C; Galimberti M; Lucarelli G; Angelucci E; Polchi P; Baronciani D; Erer B; Sotti G
    Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
    Doney K; Leisenring W; Storb R; Appelbaum FR
    Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.
    Socié G; Curtis RE; Deeg HJ; Sobocinski KA; Filipovich AH; Travis LB; Sullivan KM; Rowlings PA; Kingma DW; Banks PM; Travis WD; Witherspoon RP; Sanders J; Jaffe ES; Horowitz MM
    J Clin Oncol; 2000 Jan; 18(2):348-57. PubMed ID: 10637249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.
    Storb R; Thomas ED; Weiden PL; Buckner CD; Clift RA; Fefer A; Fernando LP; Giblett ER; Goodell BW; Johnson FL; Lerner KG; Neiman PE; Sanders JE
    Blood; 1976 Dec; 48(6):817-41. PubMed ID: 11859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation in severe aplastic anemia using cyclophosphamide and thoracoabdominal irradiation.
    Gluckman E; Devergie A; Benbunan A; Bridier A; Dutreix J
    Prog Clin Biol Res; 1984; 148():325-33. PubMed ID: 6379670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.